Skip to main content
IKT logo

IKT · Inhibikase Therapeutics, Inc. · Documents

Track IKT — free
$1.32 +0.02 (+1.54%) At close · Nov 20 Q2 2024 earnings call transcript
Market Cap
$185.16M
Shares
140.27M
Volume · Nov 20 1.11M Avg daily vol (3M) 580.26K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Mar 27
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $260.5K ▲ 111.0% Net loss $19.03M Diluted EPS -$3.57
2023
Mar 31
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $123.44K ▼ 96.0% Net loss $18.05M Diluted EPS -$0.72
Showing 51–100 of 156 documents
Key facts CIK 1750149 CUSIP 45719W205 13F (30d) 109 filings 103 filers Visit website Investor relations